Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

Diabetes mellitus (DM), a metabolic disorder that leads to chronic hyperglycemia, is one of the topmost global public health concerns according to the International Diabetes Federation. Adropin is a peptide hormone that is primarily involved in energy homeostasis, but its involvement in other biological activities such as lowering hyperlipidemia, and diminishing insulin resistance has also been reported. In this study, we aimed to explore additional effects of adropin on oxidative stress, inflammation, and cell proliferation in an animal model of type 1 DM.

• Publication year

  2025

• Venue

  Animal Models and Experimental Medicine

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ame2.70092PMID 41215702PMCID 12884442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050.

  2025cited by this paper
• Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

  2025cited by this paper
• Adropin may enhance life span and function of corpus luteum by improving antioxidant potential in adult mouse.

  2024cited by this paper
• Adropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus

  2024cited by this paper
• Unveiling the multifaceted role of adropin in various diseases (Review)

  2024cited by this paper
• Adropin deficiency worsens TNBS-induced colitis.

  2023cited by this paper
• High Level of Adropin Promotes the Progression of Pancreatic Ductal Adenocarcinoma.

  2023cited by this paper
• Possible mitigating effect of adropin on lung injury in diabetic rats: Targeting the role of Rho A/Rho‐associated kinase pathway

  2023cited by this paper
• Adropin Carried by Reactive Oxygen Species-Responsive Nanocapsules Ameliorates Renal Lipid Toxicity in Diabetic Mice.

  2022cited by this paper
• Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway

  2022cited by this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cited by this paper
• A Synopsis of the Associations of Oxidative Stress, ROS, and Antioxidants with Diabetes Mellitus

  2022cited by this paper
• Adropin’s Role in Energy Homeostasis and Metabolic Disorders

  2022cited by this paper
• Circulating levels of adropin and overweight/obesity: a systematic review and meta-analysis of observational studies

  2021cited by this paper
• Pathophysiology of diabetes mellitus complications: Metabolic events and control

  2021cited by this paper
• Adropin suppresses insulin expression and secretion in INS-1E cells and rat pancreatic islets.

  2020cited by this paper
• Adropin as A Fat-Burning Hormone with Multiple Functions—Review of a Decade of Research

  2020cited by this paper
• Pathophysiology of Type 2 Diabetes Mellitus

  2020cited by this paper
• Placental growth factor in beta cells plays an essential role in gestational beta-cell growth

  2020cited by this paper
• The association of serum and vitreous adropin concentrations with diabetic retinopathy

  2019cited by this paper
• Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes.

  2019cited by this paper
• Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity

  2018cited by this paper
• Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation

  2018cited by this paper
• Ki-67: more than a proliferation marker

  2018cited by this paper
• Low Serum Adropin Levels are Associated with Coronary Slow Flow Phenomenon.

  2018cited by this paper
• The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

  2018cited by this paper
• G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells.

  2017cited by this paper
• Adropin deficiency worsens HFD-induced metabolic defects

  2017cited by this paper
• Effects of Chronic and Intermittent Calorie Restriction on Adropin Levels in Breast Cancer

  2017cited by this paper
• Association of Serum Adropin Concentrations with Diabetic Nephropathy

  2016cited by this paper
• Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury

  2016cited by this paper
• Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats.

  2016cited by this paper
• [Pathophysiology of type 2 diabetes mellitus].

  2015cited by this paper
• Diabetes mellitus and oxidative stress—A concise review

  2015cited by this paper
• Pre-Eclampsia-Associated Reduction in Placental Growth Factor Impaired Beta Cell Proliferation Through PI3k Signalling

  2015cited by this paper
• Type 1 diabetes.

  2014cited by this paper
• Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes

  2013cited by this paper
• Adropin Is a Novel Regulator of Endothelial Function

  2010influential reference
• Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot Randomized, Placebo-Controlled, Double-Blind Study

  2009cited by this paper
• Etanercept Treatment in Children With New-Onset Type 1 Diabetes

  2009cited by this paper
• Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

  2009cited by this paper
• Pancreatic stem cells

  2008cited by this paper
• Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.

  2008cited by this paper
• Glutathione metabolism and its implications for health.

  2004cited by this paper
• Hepatic stem cells.

  2002cited by this paper
• Type 1 diabetes

  2002cited by this paper
• Pancreatic stem cells

  2002cited by this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access Hyperglycemia Induces Differential Change in Oxidative Stress at Gene Expression and Functional Levels in Huvec and Hmvec

  year unknowncited by this paper

• Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

  2025cites this paper